Since 2001, Mike Simpson has been a group leader for the Nanofabrication Research Laboratory and theme leader in the Center for Nanophase Materials Sciences. His research focus includes noise biology, nano-enabled synthetic biology and controlled synthesis and directed assembly of carbon nanostructures.
Filter Corporate Fellows
Corporate Fellow Type
Year
- (-) 2014 (1)
- (-) 2008 (3)
- (-) 2006 (1)
- (-) 1999 (3)
- (-) 1998 (2)
- (-) 1994 (2)
- (-) 1992 (2)
- (-) 1991 (1)
- (-) 1987 (1)
- (-) 1986 (1)
- (-) 1985 (3)
- (-) 1979 (5)
- 2022 (1)
- 2020 (1)
- 2017 (1)
- 2016 (2)
- 2015 (2)
- 2013 (2)
- 2012 (1)
- 2010 (1)
- 2009 (1)
- 2007 (2)
- 2005 (3)
- 2004 (2)
- 2003 (3)
- 2002 (2)
- 2001 (2)
- 2000 (1)
- 1997 (2)
- 1996 (3)
- 1990 (1)
- 1989 (1)
- 1988 (2)
- 1983 (2)
- 1976 (2)
All Corporate Fellow summaries reflect the awardee and ORNL at the time the fellowship was awarded.
2014
2008
For outstanding scientific, programmatic, and institutional contributions to ORNL in advanced computational structural mechanics and nuclear safety technologies.
For pioneering the application of chaos theory and nonlinear dynamics to energy technologies, including gas-fluidized beds, internal combustion engines, and pulsed combustion.
For pioneering research and distinguished contributions to the field of high-temperature superconductors, including fundamental materials science advances and technical innovations that enable commercialization.
2006
For his leadership in light-water reactor development, reactor safety, and the disposition of uranium waste.
1999
For pioneering accomplishments in the fields of global optimization, artificial neural networks, and high performance computing based on quantum devices.
For distinguished contributions to energy policy research and analysis for transportation, and for advancing understanding of the transportation sector's role in energy and environmental concerns.
For fundamental research establishing fission-imposed limits on rotating nuclei, and for extensive studies of heavy ion reactions from low to ultrarelativistic energies.
1998
For international leadership in developing innovative therapeutic and diagnostic applications of radionuclides for nuclear medicine.
For expertise in developing neutron detection technologies used in scientific research and in nuclear weapon and arms control verification.